Inventor · disambiguated record
Chad Euler
Also filed as: EULER CHAD
9 granted patents·5 pending applications·23 citations·filing 2009–2021
84Inventor score
Top patents by PatentIndex Score
14 records- 0191US9034322B2Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaFISCHETTI VINCENT A·Filed 2012·Granted May 19, 2015·19 cites·14 claims
- 0276US10544407B2Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaUNIV ROCKEFELLER·Filed 2017·Granted Jan 28, 2020·1 cites·12 claims
- 0376US2022064615A1Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 0475US11155799B2Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaUNIV ROCKEFELLER·Filed 2019·Granted Oct 26, 2021·0 cites·12 claims
- 0575US10053681B2Chimeric bacteriophage lysin with activity against staphylococci bacteriaUNIV ROCKEFELLER·Filed 2014·Granted Aug 21, 2018·2 cites·18 claims
- 0675US2023167427A9Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 0774US11827911B2Chimeric bacteriophage lysin with activity against Staphylococci bacteriaUNIV ROCKEFELLER·Filed 2021·Granted Nov 28, 2023·0 cites·20 claims
- 0871US9914915B2Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaFISCHETTI VINCENT A·Filed 2015·Granted Mar 13, 2018·1 cites·16 claims
- 0970US11111484B2Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteriaUNIV ROCKEFELLER·Filed 2019·Granted Sep 7, 2021·0 cites·23 claims
- 1067US8840900B2Chimeric bacteriophage lysin with activity against Staphylococci bacteriaFISCHETTI VINCENT A·Filed 2009·Granted Sep 23, 2014·0 cites·23 claims
- 1160US11015182B2Chimeric bacteriophage lysin with activity against staphylococci bacteriaUNIV ROCKEFELLER·Filed 2018·Granted May 25, 2021·0 cites·25 claims
- 1254US2022024992A1Compositions and methods comprising lysocins as bioengineered antimicrobials for use in targeting gram-negative bacteriaUNIV ROCKEFELLER·Filed 2019·Application pending·0 cites
- 1348US2021062137A1Recombinant pseudomonas aeruginosa lysinsUNIV ROCKEFELLER·Filed 2018·Application pending·0 cites
- 1441US2018353575A1Clostridium difficile bacteriophage lysins for detection and treatment of clostridium difficile bacteria infectionUNIV ROCKEFELLER·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →